Homeostatic changes of the endocannabinoid system in Parkinson's disease
Identifieur interne : 001634 ( Main/Exploration ); précédent : 001633; suivant : 001635Homeostatic changes of the endocannabinoid system in Parkinson's disease
Auteurs : Valerio Pisani [Italie] ; Graziella Madeo [Italie] ; Annalisa Tassone [Italie] ; Giuseppe Sciamanna [Italie] ; Mauro Maccarrone [Italie] ; Paolo Stanzione [Italie] ; Antonio Pisani [Italie]Source :
- Movement Disorders [ 0885-3185 ] ; 2011-02-01.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
- Animals, Basal ganglion, Brain (metabolism), Cannabinoid, Cannabinoid Receptor Modulators (metabolism), Dopamine, Endocannabinoids, Humans, Nervous system diseases, Parkinson Disease (metabolism), Parkinson disease, Parkinson's disease, Receptors, Cannabinoid (metabolism), anandamide, basal ganglia, dopamine, endocannabinoids.
- MESH :
- chemical , metabolism : Cannabinoid Receptor Modulators, Receptors, Cannabinoid.
- metabolism : Brain, Parkinson Disease.
- Animals, Endocannabinoids, Humans.
Abstract
Endocannabinoids (eCBs) are endogenous lipids that bind principally type‐1 and type‐2 cannabinoid (CB1 and CB2) receptors. N‐Arachidonoylethanolamine (AEA, anandamide) and 2‐arachidonoylglycerol (2‐AG) are the best characterized eCBs that are released from membrane phospholipid precursors through multiple biosynthetic pathways. Together with their receptors and metabolic enzymes, eCBs form the so‐called “eCB system”. The later has been involved in a wide variety of actions, including modulation of basal ganglia function. Consistently, both eCB levels and CB1 receptor expression are high in several basal ganglia regions, and more specifically in the striatum and in its target projection areas. In these regions, the eCB system establishes a close functional interaction with dopaminergic neurotransmission, supporting a relevant role for eCBs in the control of voluntary movements. Accordingly, compelling experimental and clinical evidence suggests that a profound rearrangement of the eCB system in the basal ganglia follows dopamine depletion, as it occurs in Parkinson's disease (PD). In this article, we provide a brief survey of the evidence that the eCB system changes in both animal models of, and patients suffering from, PD. A striking convergence of findings is observed between both rodent and primate models and PD patients, indicating that the eCB system undergoes dynamic, adaptive changes, aimed at restoring an apparent homeostasis within the basal ganglia network. © 2010 Movement Disorder Society
Url:
DOI: 10.1002/mds.23457
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000878
- to stream Istex, to step Curation: 000878
- to stream Istex, to step Checkpoint: 000367
- to stream PubMed, to step Corpus: 001396
- to stream PubMed, to step Curation: 001396
- to stream PubMed, to step Checkpoint: 001314
- to stream Ncbi, to step Merge: 003028
- to stream Ncbi, to step Curation: 003028
- to stream Ncbi, to step Checkpoint: 003028
- to stream Main, to step Merge: 001688
- to stream PascalFrancis, to step Corpus: 000716
- to stream PascalFrancis, to step Curation: 002602
- to stream PascalFrancis, to step Checkpoint: 000579
- to stream Main, to step Merge: 001B69
- to stream Main, to step Curation: 001634
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Homeostatic changes of the endocannabinoid system in Parkinson's disease</title><author><name sortKey="Pisani, Valerio" sort="Pisani, Valerio" uniqKey="Pisani V" first="Valerio" last="Pisani">Valerio Pisani</name></author><author><name sortKey="Madeo, Graziella" sort="Madeo, Graziella" uniqKey="Madeo G" first="Graziella" last="Madeo">Graziella Madeo</name></author><author><name sortKey="Tassone, Annalisa" sort="Tassone, Annalisa" uniqKey="Tassone A" first="Annalisa" last="Tassone">Annalisa Tassone</name></author><author><name sortKey="Sciamanna, Giuseppe" sort="Sciamanna, Giuseppe" uniqKey="Sciamanna G" first="Giuseppe" last="Sciamanna">Giuseppe Sciamanna</name></author><author><name sortKey="Maccarrone, Mauro" sort="Maccarrone, Mauro" uniqKey="Maccarrone M" first="Mauro" last="Maccarrone">Mauro Maccarrone</name></author><author><name sortKey="Stanzione, Paolo" sort="Stanzione, Paolo" uniqKey="Stanzione P" first="Paolo" last="Stanzione">Paolo Stanzione</name></author><author><name sortKey="Pisani, Antonio" sort="Pisani, Antonio" uniqKey="Pisani A" first="Antonio" last="Pisani">Antonio Pisani</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:6B09BB1C4FEB29D0916B30046684AFA50F2528B0</idno><date when="2011" year="2011">2011</date><idno type="doi">10.1002/mds.23457</idno><idno type="url">https://api.istex.fr/document/6B09BB1C4FEB29D0916B30046684AFA50F2528B0/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">000878</idno><idno type="wicri:Area/Istex/Curation">000878</idno><idno type="wicri:Area/Istex/Checkpoint">000367</idno><idno type="wicri:doubleKey">0885-3185:2011:Pisani V:homeostatic:changes:of</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:21412829</idno><idno type="wicri:Area/PubMed/Corpus">001396</idno><idno type="wicri:Area/PubMed/Curation">001396</idno><idno type="wicri:Area/PubMed/Checkpoint">001314</idno><idno type="wicri:Area/Ncbi/Merge">003028</idno><idno type="wicri:Area/Ncbi/Curation">003028</idno><idno type="wicri:Area/Ncbi/Checkpoint">003028</idno><idno type="wicri:Area/Main/Merge">001688</idno><idno type="wicri:source">INIST</idno><idno type="RBID">Pascal:11-0188449</idno><idno type="wicri:Area/PascalFrancis/Corpus">000716</idno><idno type="wicri:Area/PascalFrancis/Curation">002602</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">000579</idno><idno type="wicri:doubleKey">0885-3185:2011:Pisani V:homeostatic:changes:of</idno><idno type="wicri:Area/Main/Merge">001B69</idno><idno type="wicri:Area/Main/Curation">001634</idno><idno type="wicri:Area/Main/Exploration">001634</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Homeostatic changes of the endocannabinoid system in Parkinson's disease</title><author><name sortKey="Pisani, Valerio" sort="Pisani, Valerio" uniqKey="Pisani V" first="Valerio" last="Pisani">Valerio Pisani</name><affiliation wicri:level="3"><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Neuroscience, University of Rome Tor Vergata, Rome</wicri:regionArea><placeName><settlement type="city">Rome</settlement><region nuts="2">Latium</region></placeName></affiliation><affiliation wicri:level="3"><country xml:lang="fr">Italie</country><wicri:regionArea>Neurophysiology Lab, Fondazione Santa Lucia IRCCS, Rome</wicri:regionArea><placeName><settlement type="city">Rome</settlement><region nuts="2">Latium</region></placeName></affiliation></author><author><name sortKey="Madeo, Graziella" sort="Madeo, Graziella" uniqKey="Madeo G" first="Graziella" last="Madeo">Graziella Madeo</name><affiliation wicri:level="3"><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Neuroscience, University of Rome Tor Vergata, Rome</wicri:regionArea><placeName><settlement type="city">Rome</settlement><region nuts="2">Latium</region></placeName></affiliation><affiliation wicri:level="3"><country xml:lang="fr">Italie</country><wicri:regionArea>Neurophysiology Lab, Fondazione Santa Lucia IRCCS, Rome</wicri:regionArea><placeName><settlement type="city">Rome</settlement><region nuts="2">Latium</region></placeName></affiliation></author><author><name sortKey="Tassone, Annalisa" sort="Tassone, Annalisa" uniqKey="Tassone A" first="Annalisa" last="Tassone">Annalisa Tassone</name><affiliation wicri:level="3"><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Neuroscience, University of Rome Tor Vergata, Rome</wicri:regionArea><placeName><settlement type="city">Rome</settlement><region nuts="2">Latium</region></placeName></affiliation><affiliation wicri:level="3"><country xml:lang="fr">Italie</country><wicri:regionArea>Neurophysiology Lab, Fondazione Santa Lucia IRCCS, Rome</wicri:regionArea><placeName><settlement type="city">Rome</settlement><region nuts="2">Latium</region></placeName></affiliation></author><author><name sortKey="Sciamanna, Giuseppe" sort="Sciamanna, Giuseppe" uniqKey="Sciamanna G" first="Giuseppe" last="Sciamanna">Giuseppe Sciamanna</name><affiliation wicri:level="3"><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Neuroscience, University of Rome Tor Vergata, Rome</wicri:regionArea><placeName><settlement type="city">Rome</settlement><region nuts="2">Latium</region></placeName></affiliation><affiliation wicri:level="3"><country xml:lang="fr">Italie</country><wicri:regionArea>Neurophysiology Lab, Fondazione Santa Lucia IRCCS, Rome</wicri:regionArea><placeName><settlement type="city">Rome</settlement><region nuts="2">Latium</region></placeName></affiliation></author><author><name sortKey="Maccarrone, Mauro" sort="Maccarrone, Mauro" uniqKey="Maccarrone M" first="Mauro" last="Maccarrone">Mauro Maccarrone</name><affiliation wicri:level="3"><country xml:lang="fr">Italie</country><wicri:regionArea>Neurophysiology Lab, Fondazione Santa Lucia IRCCS, Rome</wicri:regionArea><placeName><settlement type="city">Rome</settlement><region nuts="2">Latium</region></placeName></affiliation><affiliation wicri:level="1"><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Biomedical Sciences, University of Teramo</wicri:regionArea><wicri:noRegion>University of Teramo</wicri:noRegion></affiliation></author><author><name sortKey="Stanzione, Paolo" sort="Stanzione, Paolo" uniqKey="Stanzione P" first="Paolo" last="Stanzione">Paolo Stanzione</name><affiliation wicri:level="3"><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Neuroscience, University of Rome Tor Vergata, Rome</wicri:regionArea><placeName><settlement type="city">Rome</settlement><region nuts="2">Latium</region></placeName></affiliation><affiliation wicri:level="3"><country xml:lang="fr">Italie</country><wicri:regionArea>Neurophysiology Lab, Fondazione Santa Lucia IRCCS, Rome</wicri:regionArea><placeName><settlement type="city">Rome</settlement><region nuts="2">Latium</region></placeName></affiliation></author><author><name sortKey="Pisani, Antonio" sort="Pisani, Antonio" uniqKey="Pisani A" first="Antonio" last="Pisani">Antonio Pisani</name><affiliation wicri:level="3"><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Neuroscience, University of Rome Tor Vergata, Rome</wicri:regionArea><placeName><settlement type="city">Rome</settlement><region nuts="2">Latium</region></placeName></affiliation><affiliation wicri:level="3"><country xml:lang="fr">Italie</country><wicri:regionArea>Neurophysiology Lab, Fondazione Santa Lucia IRCCS, Rome</wicri:regionArea><placeName><settlement type="city">Rome</settlement><region nuts="2">Latium</region></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2011-02-01">2011-02-01</date><biblScope unit="vol">26</biblScope><biblScope unit="issue">2</biblScope><biblScope unit="page" from="216">216</biblScope><biblScope unit="page" to="222">222</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">6B09BB1C4FEB29D0916B30046684AFA50F2528B0</idno><idno type="DOI">10.1002/mds.23457</idno><idno type="ArticleID">MDS23457</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term><term>Basal ganglion</term><term>Brain (metabolism)</term><term>Cannabinoid</term><term>Cannabinoid Receptor Modulators (metabolism)</term><term>Dopamine</term><term>Endocannabinoids</term><term>Humans</term><term>Nervous system diseases</term><term>Parkinson Disease (metabolism)</term><term>Parkinson disease</term><term>Parkinson's disease</term><term>Receptors, Cannabinoid (metabolism)</term><term>anandamide</term><term>basal ganglia</term><term>dopamine</term><term>endocannabinoids</term></keywords><keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Cannabinoid Receptor Modulators</term><term>Receptors, Cannabinoid</term></keywords><keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Brain</term><term>Parkinson Disease</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Endocannabinoids</term><term>Humans</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Cannabinoïde</term><term>Dopamine</term><term>Maladie de Parkinson</term><term>Noyau gris central</term><term>Pathologie du système nerveux</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Endocannabinoids (eCBs) are endogenous lipids that bind principally type‐1 and type‐2 cannabinoid (CB1 and CB2) receptors. N‐Arachidonoylethanolamine (AEA, anandamide) and 2‐arachidonoylglycerol (2‐AG) are the best characterized eCBs that are released from membrane phospholipid precursors through multiple biosynthetic pathways. Together with their receptors and metabolic enzymes, eCBs form the so‐called “eCB system”. The later has been involved in a wide variety of actions, including modulation of basal ganglia function. Consistently, both eCB levels and CB1 receptor expression are high in several basal ganglia regions, and more specifically in the striatum and in its target projection areas. In these regions, the eCB system establishes a close functional interaction with dopaminergic neurotransmission, supporting a relevant role for eCBs in the control of voluntary movements. Accordingly, compelling experimental and clinical evidence suggests that a profound rearrangement of the eCB system in the basal ganglia follows dopamine depletion, as it occurs in Parkinson's disease (PD). In this article, we provide a brief survey of the evidence that the eCB system changes in both animal models of, and patients suffering from, PD. A striking convergence of findings is observed between both rodent and primate models and PD patients, indicating that the eCB system undergoes dynamic, adaptive changes, aimed at restoring an apparent homeostasis within the basal ganglia network. © 2010 Movement Disorder Society</div></front></TEI><affiliations><list><country><li>Italie</li></country><region><li>Latium</li></region><settlement><li>Rome</li></settlement></list><tree><country name="Italie"><region name="Latium"><name sortKey="Pisani, Valerio" sort="Pisani, Valerio" uniqKey="Pisani V" first="Valerio" last="Pisani">Valerio Pisani</name></region><name sortKey="Maccarrone, Mauro" sort="Maccarrone, Mauro" uniqKey="Maccarrone M" first="Mauro" last="Maccarrone">Mauro Maccarrone</name><name sortKey="Maccarrone, Mauro" sort="Maccarrone, Mauro" uniqKey="Maccarrone M" first="Mauro" last="Maccarrone">Mauro Maccarrone</name><name sortKey="Madeo, Graziella" sort="Madeo, Graziella" uniqKey="Madeo G" first="Graziella" last="Madeo">Graziella Madeo</name><name sortKey="Madeo, Graziella" sort="Madeo, Graziella" uniqKey="Madeo G" first="Graziella" last="Madeo">Graziella Madeo</name><name sortKey="Pisani, Antonio" sort="Pisani, Antonio" uniqKey="Pisani A" first="Antonio" last="Pisani">Antonio Pisani</name><name sortKey="Pisani, Antonio" sort="Pisani, Antonio" uniqKey="Pisani A" first="Antonio" last="Pisani">Antonio Pisani</name><name sortKey="Pisani, Valerio" sort="Pisani, Valerio" uniqKey="Pisani V" first="Valerio" last="Pisani">Valerio Pisani</name><name sortKey="Sciamanna, Giuseppe" sort="Sciamanna, Giuseppe" uniqKey="Sciamanna G" first="Giuseppe" last="Sciamanna">Giuseppe Sciamanna</name><name sortKey="Sciamanna, Giuseppe" sort="Sciamanna, Giuseppe" uniqKey="Sciamanna G" first="Giuseppe" last="Sciamanna">Giuseppe Sciamanna</name><name sortKey="Stanzione, Paolo" sort="Stanzione, Paolo" uniqKey="Stanzione P" first="Paolo" last="Stanzione">Paolo Stanzione</name><name sortKey="Stanzione, Paolo" sort="Stanzione, Paolo" uniqKey="Stanzione P" first="Paolo" last="Stanzione">Paolo Stanzione</name><name sortKey="Tassone, Annalisa" sort="Tassone, Annalisa" uniqKey="Tassone A" first="Annalisa" last="Tassone">Annalisa Tassone</name><name sortKey="Tassone, Annalisa" sort="Tassone, Annalisa" uniqKey="Tassone A" first="Annalisa" last="Tassone">Annalisa Tassone</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001634 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001634 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:6B09BB1C4FEB29D0916B30046684AFA50F2528B0
|texte= Homeostatic changes of the endocannabinoid system in Parkinson's disease
}}
| This area was generated with Dilib version V0.6.23. |  |